Xtant Net Working Capital vs Property Plant Equipment Analysis
XTNT Stock | USD 0.40 0.01 2.44% |
Xtant Medical financial indicator trend analysis is more than just analyzing Xtant Medical Holdings current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Xtant Medical Holdings is a good investment. Please check the relationship between Xtant Medical Net Working Capital and its Property Plant Equipment accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xtant Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Net Working Capital vs Property Plant Equipment
Net Working Capital vs Property Plant Equipment Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Xtant Medical Holdings Net Working Capital account and Property Plant Equipment. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Xtant Medical's Net Working Capital and Property Plant Equipment is -0.03. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Property Plant Equipment in the same time period over historical financial statements of Xtant Medical Holdings, assuming nothing else is changed. The correlation between historical values of Xtant Medical's Net Working Capital and Property Plant Equipment is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of Xtant Medical Holdings are associated (or correlated) with its Property Plant Equipment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant Equipment has no effect on the direction of Net Working Capital i.e., Xtant Medical's Net Working Capital and Property Plant Equipment go up and down completely randomly.
Correlation Coefficient | -0.03 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Net Working Capital
Property Plant Equipment
Most indicators from Xtant Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Xtant Medical Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xtant Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Xtant Medical's Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 31.54 in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 9.6 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 32.5M | 32.1M | 55.5M | 34.0M | Total Revenue | 55.3M | 58.0M | 91.3M | 53.7M |
Xtant Medical fundamental ratios Correlations
Click cells to compare fundamentals
Xtant Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Xtant Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 43.2M | 41.5M | 54.7M | 60.2M | 92.6M | 60.0M | |
Other Current Liab | 7K | 5.7M | 3.9M | 5.0M | 9.5M | 10.0M | |
Total Current Liabilities | 9.4M | 25.6M | 11.1M | 15.2M | 23.0M | 16.0M | |
Total Stockholder Equity | (44.2M) | 14.5M | 30.9M | 34.2M | 51.3M | 53.9M | |
Net Debt | 73.3M | 16.2M | (1.4M) | (3.2M) | 17.8M | 17.0M | |
Retained Earnings | (223.3M) | (230.3M) | (235.2M) | (243.7M) | (243.0M) | (230.9M) | |
Accounts Payable | 2.2M | 2.3M | 2.6M | 3.5M | 7.1M | 4.9M | |
Cash | 5.2M | 2.3M | 18.2M | 20.3M | 5.7M | 5.8M | |
Cash And Short Term Investments | 5.2M | 2.3M | 18.2M | 20.3M | 5.7M | 5.8M | |
Net Receivables | 10.1M | 6.9M | 7.2M | 10.9M | 20.7M | 21.8M | |
Common Stock Shares Outstanding | 13.2M | 28.5M | 85.5M | 94.1M | 126.8M | 133.1M | |
Liabilities And Stockholders Equity | 43.2M | 41.5M | 54.7M | 60.2M | 92.6M | 60.0M | |
Inventory | 16.1M | 21.4M | 17.9M | 17.3M | 36.9M | 38.7M | |
Other Current Assets | 784K | 1.5M | 988K | 1.6M | 1.5M | 830.2K | |
Other Stockholder Equity | 179.1M | 244.9M | 266.1M | 277.8M | 294.3M | 309.0M | |
Total Liab | 87.4M | 27.0M | 23.8M | 26.1M | 41.3M | 60.8M | |
Total Current Assets | 32.2M | 31.4M | 44.3M | 49.3M | 64.9M | 33.6M | |
Short Long Term Debt Total | 78.5M | 18.5M | 16.8M | 17.1M | 23.6M | 22.4M | |
Property Plant And Equipment Net | 6.8M | 6.0M | 6.5M | 7.2M | 10.2M | 7.8M | |
Non Current Assets Total | 10.9M | 10.1M | 10.4M | 10.9M | 27.7M | 28.2M | |
Non Currrent Assets Other | 394K | 402K | 287K | 197K | 141K | 134.0K | |
Non Current Liabilities Total | 78.0M | 1.3M | 12.7M | 10.8M | 18.3M | 17.4M | |
Property Plant And Equipment Gross | 6.8M | 4.3M | 6.5M | 7.2M | 29.9M | 31.4M | |
Short Term Debt | 570K | 17.7M | 4.6M | 6.8M | 6.4M | 3.9M | |
Intangible Assets | 515K | 457K | 400K | 344K | 10.1M | 7.8M | |
Other Assets | 394K | 2.1M | 287K | 197K | 1.0 | 0.95 | |
Long Term Debt | 77.9M | 76.2M | 11.8M | 9.7M | 17.2M | 16.3M | |
Property Plant Equipment | 6.8M | 4.3M | 6.5M | 5.8M | 6.7M | 7.6M | |
Retained Earnings Total Equity | (215.0M) | (223.3M) | (230.3M) | (243.7M) | (219.3M) | (208.3M) | |
Net Tangible Assets | (47.9M) | 10.9M | 27.3M | 30.6M | 35.2M | 37.0M | |
Long Term Debt Total | 138.6M | 78.1M | 76.2M | 9.7M | 8.7M | 8.3M | |
Capital Surpluse | 171.3M | 179.1M | 244.9M | 277.8M | 319.5M | 177.0M | |
Capital Lease Obligations | 2.3M | 1.7M | 1.4M | 1.7M | 1.8M | 1.6M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.